Rockwell Med (RMTI) Stock Statistics & Valuation Metrics

Rockwell Med has a market cap or net worth of CHF26.68M. The enterprise value is CHF10.93.

Rockwell Med has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Rockwell Med’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -9.49%.

The current PE Ratio of Rockwell Med is ―. Rockwell Med’s PEG ratio is -0.01.

In the last 12 months, Rockwell Med had revenue of 69.26M and earned -5.31M in profits. Earnings per share was -1.50.

In the last 12 months, operating cash flow was 2.90M and capital expenditures -1.36M, giving a free cash flow of 1.54M billion.

Rockwell Med pays an annual dividend of ―, resulting in a dividend yield of ―

Rockwell Med upcoming earnings date is Nov 16, 2026, After Close (Confirmed).

Rockwell Med as a current ratio of 3.98, with Debt / Equity ratio of 39.71%

In the past 12 months, Rockwell Med has paid 0.00 in taxes.

Rockwell Med EV to EBITDA ratio is -15.90, with an EV/FCF ratio of -26.45.

Rockwell Med has CHF24.80M in cash and marketable securities with CHF13.93M in debt, giving a net cash position of CHF10.86M billion.

Gross margin is 17.71%, with operating margin of -6.77%, and net profit margin of -7.67%.

The average price target for Rockwell Med is CHF16.49, which is 11.43% higher than the current price. The consensus rating is Moderate Buy